PULM – Pulmatrix Inc
Pulmatrix, Inc.PULM
$8.92Name : Pulmatrix, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $32,578,338.00
EPSttm : -2.64
Pulmatrix, Inc.
$8.92
1.00%$0.09Float Short %
1.45
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
4.34
Price
8.92
Target Price
10
Analyst Recom
1
Performance Q
32.74
Relative Volume
0.28
Beta
1.68
Ticker: PULM
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-01-23 | PULM | 6.89 | N/A | N/A | 0 |
| 2025-01-24 | PULM | 7.27 | N/A | N/A | 0 |
| 2025-01-27 | PULM | 7.07 | N/A | N/A | 0 |
| 2025-01-28 | PULM | 7 | N/A | N/A | 0 |
| 2025-01-29 | PULM | 7.9 | N/A | N/A | 0 |
| 2025-01-30 | PULM | 7.67 | N/A | N/A | 0 |
| 2025-01-31 | PULM | 7.69 | N/A | N/A | 0 |
| 2025-02-03 | PULM | 7.48 | N/A | N/A | 0 |
| 2025-02-04 | PULM | 7.02 | N/A | N/A | 0 |
| 2025-02-05 | PULM | 7.39 | N/A | N/A | 0 |
| 2025-02-06 | PULM | 7.58 | N/A | N/A | 0 |
| 2025-02-07 | PULM | 7.24 | N/A | N/A | 0 |
| 2025-02-10 | PULM | 7.58 | N/A | N/A | 0 |
| 2025-02-11 | PULM | 7.48 | N/A | N/A | 0 |
| 2025-02-12 | PULM | 7.47 | N/A | N/A | 0 |
| 2025-02-13 | PULM | 7.38 | N/A | N/A | 0 |
| 2025-02-14 | PULM | 7.76 | N/A | N/A | 0 |
| 2025-02-18 | PULM | 10 | N/A | N/A | 0 |
| 2025-02-19 | PULM | 9.36 | N/A | N/A | 0 |
| 2025-02-20 | PULM | 9.1 | N/A | N/A | 0 |
| 2025-02-21 | PULM | 8.81 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-01-23 | PULM | 6.89 | - | - | -4.34 |
| 2025-01-24 | PULM | 7.24 | - | - | -4.34 |
| 2025-01-27 | PULM | 6.97 | - | - | -4.34 |
| 2025-01-28 | PULM | 7.01 | - | - | -4.34 |
| 2025-01-29 | PULM | 7.74 | - | - | -4.34 |
| 2025-01-30 | PULM | 7.67 | - | - | -4.34 |
| 2025-01-31 | PULM | 7.70 | - | - | -4.34 |
| 2025-02-03 | PULM | 7.50 | - | - | -4.34 |
| 2025-02-04 | PULM | 7.03 | - | - | -4.34 |
| 2025-02-05 | PULM | 7.39 | - | - | -4.34 |
| 2025-02-06 | PULM | 7.58 | - | - | -4.34 |
| 2025-02-07 | PULM | 7.29 | - | - | -4.34 |
| 2025-02-10 | PULM | 7.58 | - | - | -4.34 |
| 2025-02-11 | PULM | 7.58 | - | - | -4.34 |
| 2025-02-12 | PULM | 7.39 | - | - | -4.34 |
| 2025-02-13 | PULM | 7.49 | - | - | -4.34 |
| 2025-02-14 | PULM | 7.73 | - | - | -4.34 |
| 2025-02-18 | PULM | 9.83 | - | - | -4.34 |
| 2025-02-19 | PULM | 9.39 | - | - | -4.34 |
| 2025-02-20 | PULM | 8.96 | - | - | -4.34 |
| 2025-02-21 | PULM | 8.92 | - | - | -4.34 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-01-23 | PULM | 0 | 5.20 | 1.08 |
| 2025-01-24 | PULM | 0 | 5.20 | 1.08 |
| 2025-01-27 | PULM | 0 | 5.20 | 1.08 |
| 2025-01-28 | PULM | 0 | 5.20 | 1.31 |
| 2025-01-29 | PULM | 0 | 5.20 | 1.31 |
| 2025-01-30 | PULM | 0 | 5.20 | 1.31 |
| 2025-01-31 | PULM | 0 | 5.20 | 1.31 |
| 2025-02-03 | PULM | 0 | 5.20 | 1.31 |
| 2025-02-04 | PULM | 0 | 5.20 | 1.31 |
| 2025-02-05 | PULM | 0 | 5.20 | 1.31 |
| 2025-02-06 | PULM | 0 | 5.20 | 1.31 |
| 2025-02-07 | PULM | 0 | 5.20 | 1.31 |
| 2025-02-10 | PULM | 0 | 5.28 | 1.31 |
| 2025-02-11 | PULM | 0 | 5.28 | 1.31 |
| 2025-02-12 | PULM | 0 | 5.28 | 1.45 |
| 2025-02-13 | PULM | 0 | 5.28 | 1.45 |
| 2025-02-14 | PULM | 0 | 5.28 | 1.45 |
| 2025-02-18 | PULM | 0 | 31.50 | 1.45 |
| 2025-02-19 | PULM | 0 | 31.50 | 1.45 |
| 2025-02-20 | PULM | 0 | 31.50 | 1.45 |
| 2025-02-21 | PULM | 0 | 31.50 | 1.45 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-1.04
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
31.5
Beta
1.68
Average Sales Estimate Current Quarter
2
Average Sales Estimate Next Quarter
Fair Value
Quality Score
21
Growth Score
46
Sentiment Score
100
Actual DrawDown %
85.3
Max Drawdown 5-Year %
-96.9
Target Price
10
P/E
Forward P/E
PEG
P/S
3.25
P/B
2.98
P/Free Cash Flow
EPS
-2.64
Average EPS Est. Cur. Y
-4.34
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-96.51
Relative Volume
0.28
Return on Equity vs Sector %
-107.7
Return on Equity vs Industry %
-92
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Pulmatrix, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 22
Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.
stock quote shares PULM – Pulmatrix Inc Stock Price stock today
news today PULM – Pulmatrix Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PULM – Pulmatrix Inc yahoo finance google finance
stock history PULM – Pulmatrix Inc invest stock market
stock prices PULM premarket after hours
ticker PULM fair value insiders trading